Cardiovascular diseases Trials in Pittsburgh, United States
Conditions / Cardiovascular diseases / Pittsburgh, United States
Clinical trials for Cardiovascular diseases investigate a range of treatment strategies and patient populations.
51 total trials for this combination
Showing top 10 of 51 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05655936 | Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial | RECRUITING | NA |
| NCT05882045 | A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING | PHASE3 |
| NCT03626688 | A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients | COMPLETED | — |
| NCT02993406 | Evaluation of Major Cardiovascular Events in Participants With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo | COMPLETED | PHASE3 |
| NCT02638129 | Naltrexone/Bupropion Cardiovascular Outcomes Study | TERMINATED | PHASE4 |
| NCT00005133 | Cardiovascular Health Study (CHS) | ACTIVE_NOT_RECRUITING | — |
| NCT05803421 | A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk | COMPLETED | — |
| NCT05198674 | SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN | ACTIVE_NOT_RECRUITING | NA |
| NCT03683186 | A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension | ENROLLING_BY_INVITATION | PHASE3 |